-
Signature
-
/s/ William Cook, as Attorney-in-fact for David Scadden
-
Stock symbol
-
AGIO
-
Transactions as of
-
Jul 10, 2025
-
Transactions value $
-
-$30,674
-
Form type
-
4
-
Date filed
-
7/15/2025, 04:05 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Scadden David |
Director |
C/O AGIOS PHARMACEUTICALS, INC., 88 SIDNEY STREET, CAMBRIDGE |
/s/ William Cook, as Attorney-in-fact for David Scadden |
2025-07-15 |
0001707715 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AGIO |
Common stock |
Options Exercise |
$25.3K |
+1.4K |
+7.95% |
$18.09 |
19K |
Jul 10, 2025 |
Direct |
F1 |
| transaction |
AGIO |
Common stock |
Sale |
-$56K |
-1.4K |
-7.37% |
$40.00 |
17.6K |
Jul 10, 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
AGIO |
Stock options (right to buy) |
Options Exercise |
$0 |
-1.4K |
-4.81% |
$0.00 |
27.7K |
Jul 10, 2025 |
Common stock |
1.4K |
$18.09 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: